Health Care/Hospital

Olympus Signs Global Distribution Agreement with EndoRobotics, Adds Robot-Assisted Technologies to EndoTherapy Portfolio

Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures TOKYO, May 4, 2026 /PRNewswire/ -- Olympus Corporation (Olympus), a global ...

2026-05-04 15:00 4610

TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE

SINGAPORE, May 4, 2026 /PRNewswire/ -- Edwards Lifesciences, the leading global structural heart innovation company, recently announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were p...

2026-05-04 14:00 4308

XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway

SHENZHEN, China, May 4, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic partnership with PharmaEngine (4162.TWO) PEP08, a next-generation PRMT5 inhibitor discovered via XtalPi's platform, has succes...

2026-05-04 08:19 4304

TLX101-Px (Pixlumi®) MAA Accepted in Europe

MELBOURNE, Australia and INDIANAPOLIS, May 1, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the marketing authorization application (MAA) filed in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer...

2026-05-01 08:48 6840

TraceLink Wins 2026 Globee® Cybersecurity Award as OPUS Sets the Standard for Secure, Agentic Supply Chain Operations

GxP-aligned, industrial-grade platform secures the world's largest Agentic Business Network—enabling trusted, real-time execution across global supply chains Summary TraceLink has been named a winner in the 2026 Globee® Awards for Cybersecurity, recognizing the company's leadership in securing c...

2026-04-30 22:00 4951

Park Systems Launches NX1: The Highest Resolution AFM for Atomic-Scale Imaging in Ambient Conditions

GWACHEON, South Korea, April 30, 2026 /PRNewswire/ -- Park Systems Corp., the world's leading provider of atomic force microscopy (AFM) solutions, today announced the launch of the NX1 — a compact, high-performance AFM that delivers atomic resolution imaging in ambient conditions. Developed in co...

2026-04-30 20:44 4156

For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health

A first-of-its-kind multi-country adult respiratory health awareness campaign is now live across Singapore, Malaysia, Indonesia, and the Philippines SINGAPORE, April 30, 2026 /PRNewswire/ -- In conjunction with World Immunisation Week, Pfizer Singapore, together with healthcare professionals, ha...

2026-04-30 18:53 4292

Malaysia Healthcare Strengthens Presence in Myanmar as Demand for Trusted Treatment Abroad Grows

KUALA LUMPUR, Malaysia, April 30, 2026 /PRNewswire/ -- For many patients in Myanmar, seeking medical care abroad is becoming an increasingly considered decision, particularly for specialised treatments, second opinions, and long-term health management. As healthcare awareness grows, more patients...

2026-04-30 16:43 4699

Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160

BEIJING, April 30, 2026 /PRNewswire/ -- Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an ...

2026-04-30 16:28 5362

For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health

MAKATI CITY, Philippines, April 30, 2026 /PRNewswire/ -- Pfizer Philippines, together with healthcare professionals, has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out across the Philippines, Malaysia, Indonesia and Singapore, ...

2026-04-30 16:14 5283

Ascendion Recognized Among India's Top 50 Best Workplaces in Health & Wellness for the Third Consecutive Year

BENGALURU, India, April 30, 2026 /PRNewswire/ -- Ascendion, an AI-native software engineering company, has been recognized among the Top 50 ofIndia's Best Workplaces™ in Health & Wellness 2026: Companies That Care, marking its third consecutive year on the list.

2026-04-30 15:54 5175

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's transition fr...

2026-04-30 13:18 5977

Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medi...

2026-04-30 12:35 4354

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D, 600 mg QD). Phase 2 clinical outcomes include: * 2L+ KRAS G12Ci–naïve NSCLC: ORR of 58.8%, mPFS of 12.2 months * 2L+ colorectal cancer (CRC): ORR of 46.9%, mPFS of 9.5 months ...

2026-04-30 11:20 4754

CMEF 2026 wraps up in Shanghai: a global stage for medical breakthroughs and future trends

SHANGHAI, April 30, 2026 /PRNewswire/ -- The 93rd China International Medical Equipment Fair (CMEF), together with its concurrent industry events, has successfully concluded on April 12 at the National Exhibition and Convention Center (Shanghai) after four days of exhibitions and exchanges. Under...

2026-04-30 10:26 3832

Taimei Technology Debuts at BioKorea 2026, Showcasing AI-Powered Clinical Research Solutions

SEOUL, South Korea, April 30, 2026 /PRNewswire/ -- Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced AI-powered clinical research technology solutions. Headq...

2026-04-30 10:00 3559

Classys Emerges as a Global Leader in Medical Aesthetics Beyond K-Beauty, Highlighting 45% Growth, 50%+ Margins, and Recurring Revenue Model

– Operations in 80+ countries with over 45,000 installed platforms and 66% international revenue mix – Consumables account for 46% of revenue, with more than 5.5 million HIFU procedures performed annually worldwide – Accelerating growth through two strategic M&A transactions over the past two yea...

2026-04-30 09:25 4178

ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in advanced immunology technologies. The partne...

2026-04-30 08:30 4744

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

HONG KONG, April 30, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the American Diabetes Association's (ADA's) 2026 Scientific Sessions, taking place June 5–8, 2026 in New Orleans, Louisiana. The presentat...

2026-04-30 08:10 4068

ACROBiosystems collaborates with Carterra, accelerating large-scale characterization of potential drug candidates

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, announces its collaboration with Carterra, a company focused on innovative technologies designed to accelerate the discovery...

2026-04-30 08:00 3725
1 ... 6789101112 ... 541

Week's Top Stories